Five-Year Trial of TASC II Type C/D Lesions Undergoing Subintimal Angioplasty or Bypass Surgery Based on Plaque Echolucency.
Presenter: Niamh Hynes,
Sherif Sultan
Up Next
Presenter: Jeffrey Nadelson
More slides +
Presenter: Patrick Tobbia
Presenter: Melissa Blondeau